Mathematical properties of weighted impact factors based on measures of prestige of the citing journals

The final publication is available at Springer via http://dx.doi.org/10.1007/s11192-015-1741-0An abstract construction for general weighted impact factors is introduced. We show that the classical weighted impact factors are particular cases of our model, but it can also be used for defining new impact measuring tools for other sources of information as repositories of datasets providing the mathematical support for a new family of altmet- rics. Our aim is to show the main mathematical properties of this class of impact measuring tools, that hold as consequences of their mathematical structure and does not depend on the definition of any given index nowadays in use. In order to show the power of our approach in a well-known setting, we apply our construction to analyze the stability of the ordering induced in a list of journals by the 2-year impact factor (IF2). We study the change of this ordering when the criterium to define it is given by the numerical value of a new weighted impact factor, in which IF2 is used for defining the weights. We prove that, if we assume that the weight associated to a citing journal increases with its IF2, then the ordering given in the list by the new weighted impact factor coincides with the order defined by the IF2. We give a quantitative bound for the errors committed. We also show two examples of weighted impact factors defined by weights associated to the prestige of the citing journal for the fields of MATHEMATICS and MEDICINE, GENERAL AND INTERNAL, checking if they satisfy the increasing behavior mentioned above.Ferrer Sapena, A.; Sánchez Pérez, EA.; González, LM.; Peset Mancebo, MF.; Aleixandre Benavent, R. (2015). Mathematical properties of weighted impact factors based on measures of prestige of the citing journals. Scientometrics. 105(3):2089-2108. https://doi.org/10.1007/s11192-015-1741-0S208921081053Ahlgren, P., & Waltman, L. (2014). The correlation between citation-based and expert-based assessments of publication channels: SNIP and SJR vs. Norwegian quality assessments. Journal of Informetrics, 8, 985–996.Aleixandre Benavent, R., Valderrama Zurián, J. C., & González Alcaide, G. (2007). Scientific journals impact factor: Limitations and alternative indicators. El Profesional de la Información, 16(1), 4–11.Altmann, K. G., & Gorman, G. E. (1998). The usefulness of impact factor in serial selection: A rank and mean analysis using ecology journals. Library Acquisitions-Practise and Theory, 22, 147–159.Arnold, D. N., & Fowler, K. K. (2011). Nefarious numbers. Notices of the American Mathematical Society, 58(3), 434–437.Beliakov, G., & James, S. (2012). Using linear programming for weights identification of generalized bonferroni means in R. In: Proceedings of MDAI 2012 modeling decisions for artificial intelligence. Lecture Notes in Computer Science, Vol. 7647, pp. 35–44.Beliakov, G., & James, S. (2011). Citation-based journal ranks: The use of fuzzy measures. Fuzzy Sets and Systems, 167, 101–119.Buela-Casal, G. (2003). Evaluating quality of articles and scientific journals. Proposal of weighted impact factor and a quality index. Psicothema, 15(1), 23–25.Dorta-Gonzalez, P., & Dorta-Gonzalez, M. I. (2013). Comparing journals from different fields of science and social science through a JCR subject categories normalized impact factor. Scientometrics, 95(2), 645–672.Dorta-Gonzalez, P., Dorta-Gonzalez, M. I., Santos-Penate, D. R., & Suarez-Vega, R. (2014). Journal topic citation potential and between-field comparisons: The topic normalized impact factor. Journal of Informetrics, 8(2), 406–418.Egghe, L., & Rousseau, R. (2002). A general frame-work for relative impact indicators. Canadian Journal of Information and Library Science, 27(1), 29–48.Gagolewski, M., & Mesiar, R. (2014). Monotone measures and universal integrals in a uniform framework for the scientific impact assessment problem. Information Sciences, 263, 166–174.Garfield, E. (2006). The history and meaning of the journal impact factor. JAMA, 295(1), 90–93.Habibzadeh, F., & Yadollahie, M. (2008). Journal weighted impact factor: A proposal. Journal of Informetrics, 2(2), 164–172.Klement, E., Mesiar, R., & Pap, E. (2010). A universal integral as common frame for Choquet and Sugeno integral. IEEE Transaction on Fuzzy System, 18, 178–187.Leydesdorff, L., & Opthof, T. (2010). Scopus’s source normalized impact per paper (SNIP) versus a journal impact factor based on fractional counting of citations. Journal of the American Society for Information Science and Technology, 61, 2365–2369.Li, Y. R., Radicchi, F., Castellano, C., & Ruiz-Castillo, J. (2013). Quantitative evaluation of alternative field normalization procedures. Journal of Informetrics, 7(3), 746–755.Moed, H. F. (2010). Measuring contextual citation impact of scientific journals. Journal of Informetrics, 4, 265–277.NISO. (2014). Alternative metrics initiative phase 1. White paper. http://www.niso.org/apps/group-public/download.php/13809/Altmetrics-project-phase1-white-paperOwlia, P., Vasei, M., Goliaei, B., & Nassiri, I. (2011). Normalized impact factor (NIF): An adjusted method for calculating the citation rate of biomedical journals. Journal of Biomedical Informatics, 44(2), 216–220.Pinski, G., & Narin, F. (1976). Citation influence for journal aggregates of scientific publications: Theory, with application to the literature of physics. Information Processing and Management, 12, 297–312.Pinto, A. C., & Andrade, J. B. (1999). Impact factor of scientific journals: What is the meaning of this parameter? Quimica Nova, 22, 448–453.Raghunathan, M. S., & Srinivas, V. (2001). Significance of impact factor with regard to mathematics journals. Current Science, 80(5), 605.Ruiz Castillo, J., & Waltman, L. (2015). Field-normalized citation impact indicators using algorithmically constructed classification systems of science. Journal of Informetrics, 9, 102–117.Saha, S., Saint, S., & Christakis, D. A. (2003). Impact factor: A valid measure of journal quality? Journal of the Medical Library Association, 91, 42–46.Torra, V., & Narukawa, Y. (2008). The h-index and the number of citations: Two fuzzy integrals. IEEE Transaction on Fuzzy System, 16, 795–797.Torres-Salinas, D., & Jimenez-Contreras, E. (2010). Introduction and comparative study of the new scientific journals citation indicators in journal citation reports and scopus. El Profesional de la Información, 19, 201–207.Waltman, L., & van Eck, N. J. (2008). Some comments on the journal weighted impact factor proposed by Habibzadeh and Yadollahie. Journal of Informetrics, 2(4), 369–372.Waltman, L., van Eck, N. J., van Leeuwen, T. N., & Visser, M. S. (2013). Some modifications to the SNIP journal impact indicator. Journal of Informetrics, 7, 272–285.Zitt, M. (2011). Behind citing-side normalization of citations: some properties of the journal impact factor. Scientometrics, 89, 329–344.Zitt, M., & Small, H. (2008). Modifying the journal impact factor by fractional citation weighting: The audience factor. Journal of the American Society for Information Science and Technology, 59, 1856–1860.Zyczkowski, K. (2010). Citation graph, weighted impact factors and performance indices. Scientometrics, 85(1), 301–315

Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity

Background: X-linked adrenoleukodystrophy (ALD) is a metabolic, peroxisomal disease that results from a mutation in the ABCD1 gene. The most severe course of ALD progression is the cerebral inflammatory and demyelinating form of the disease, cALD. To date there is very little information on the cytokine mediators in the cerebral spinal fluid (CSF) of these boys. Methodology/Principal Findings: Measurement of 23 different cytokines was performed on CSF and serum of boys with cerebral ALD and patients without ALD. Significant elevations in CSF IL-8 (29.362.2 vs 12.861.1 pg/ml, p = 0.0001), IL-1ra (166630 vs 8.666.5 pg/ml, p = 0.005), MCP-1 (610647 vs 328634 pg/ml, p = 0.002), and MIP-1b (14.261.3 vs 2.061.4 pg/ml, p,0.0001) were found in boys with cALD versus the control group. The only serum cytokine showing an elevation in the ALD group was SDF-1 (21246155 vs 11756125 pg/ml, p = 0.0001). The CSF cytokines of IL-8 and MCP-1b correlated with the Loes MRI severity score (p = 0.04 and p = 0.008 respectively), as well as the serum SDF-1 level (p = 0.002). Finally, CSF total protein was also significantly elevated in boys with cALD and correlated with both IL-8, MCP-1b (p = 0.0001 for both), as well as Loes MRI severity score (p = 0.0007). Conclusions/Significance: IL-8, IL-1ra, MCP-1, MIP-1b and CSF total protein were significantly elevated in patients with cALD; IL-8, MCP-1b, and CSF total protein levels correlated with disease severity determined by MRI. This is the largest repor

Measurement of the top-quark mass in tt¯ events with dilepton final states in pp collisions at √s = 7 TeV

Open Access: This article is distributed under the terms of the Creative Commons Attribution License.-- Chatrchyan, S. et al.The top-quark mass is measured in proton-proton collisions at s√=7 TeV using a data sample corresponding to an integrated luminosity of 5.0 fb−1 collected by the CMS experiment at the LHC. The measurement is performed in the dilepton decay channel tt¯→(ℓ+νℓb)(ℓ−ν¯¯ℓb¯), where ℓ=e,μ. Candidate top-quark decays are selected by requiring two leptons, at least two jets, and imbalance in transverse momentum. The mass is reconstructed with an analytical matrix weighting technique using distributions derived from simulated samples. Using a maximum-likelihood fit, the top-quark mass is determined to be 172.5±0.4 (stat.)±1.5 (syst.) GeV.Acknowledge support from BMWF and FWF (Austria); FNRS and FWO (Belgium); CNPq, CAPES, FAPERJ, and FAPESP (Brazil); MES (Bulgaria); CERN; CAS, MoST, and NSFC (China); COLCIENCIAS (Colombia); MSES (Croatia); RPF (Cyprus); MoER, SF0690030s09 and ERDF (Estonia); Academy of Finland, MEC, and HIP (Finland); CEA and CNRS/IN2P3 (France);BMBF, DFG, and HGF (Germany); GSRT (Greece); OTKA and NKTH (Hungary); DAE and DST (India); IPM (Iran); SFI (Ireland); INFN (Italy); NRF and WCU (Korea); LAS (Lithuania); CINVESTAV, CONACYT, SEP, and UASLP-FAI (Mexico); MSI (New Zealand); PAEC (Pakistan); MSHE and NSC (Poland); FCT (Portugal); JINR (Armenia, Belarus, Georgia, Ukraine, Uzbekistan); MON, RosAtom, RAS and RFBR (Russia); MSTD (Serbia); SEIDI and CPAN (Spain); Swiss Funding Agencies (Switzerland); NSC (Taipei); ThEP, IPST and NECTEC (Thailand); TUBITAK and TAEK (Turkey); NASU (Ukraine); STFC (United Kingdom); DOE and NSF (USA). Individuals have received support from the Marie-Curie program and the European Research Council (European Union); the Leventis Foundation; the A. P. Sloan Foundation; the Alexander von Humboldt Foundation; the Austrian Science Fund (FWF); the Belgian Federal Science Policy Office; the Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture (FRIA-Belgium); the Agentschap voor Innovatie door Wetenschap en Technologie (IWTBelgium); the Ministry of Education, Youth and Sports (MEYS) of Czech Republic; the Council of Science and Industrial Research, India; the Compagnia di San Paolo (Torino); and the HOMING PLUS program of Foundation for Polish Science, cofinanced from European Union, Regional Development Fund.Peer Reviewe

Measurement of the Top Pair Production Cross Section in the Dilepton Decay Channel in ppbar Collisions at sqrt s = 1.96 TeV

Submitted to Phys. Rev. DA measurement of the \ttbar production cross section in \ppbar collisions at $\sqrt{{\rm s}}$ = 1.96 TeV using events with two leptons, missing transverse energy, and jets is reported. The data were collected with the CDF II Detector. The result in a data sample corresponding to an integrated luminosity 2.8 fb$^{-1}$ is: \sigma_{\ttbar} = 6.27 $\pm$ 0.73(stat) $\pm$ 0.63(syst) $\pm$ 0.39(lum) pb. for an assumed top mass of 175 GeV/$c^{2}$.A measurement of the tt̅ production cross section in pp̅ collisions at √s=1.96  TeV using events with two leptons, missing transverse energy, and jets is reported. The data were collected with the CDF II detector. The result in a data sample corresponding to an integrated luminosity 2.8  fb-1 is σtt̅ =6.27±0.73(stat)±0.63(syst)±0.39(lum)  pb. for an assumed top mass of 175  GeV/c2.Peer reviewe

The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

Background: Mortality due to COVID-19 is high, especially in patients requiring mechanical ventilation. The purpose of the study is to investigate associations between mortality and variables measured during the first three days of mechanical ventilation in patients with COVID-19 intubated at ICU admission. Methods: Multicenter, observational, cohort study includes consecutive patients with COVID-19 admitted to 44 Spanish ICUs between February 25 and July 31, 2020, who required intubation at ICU admission and mechanical ventilation for more than three days. We collected demographic and clinical data prior to admission; information about clinical evolution at days 1 and 3 of mechanical ventilation; and outcomes. Results: Of the 2,095 patients with COVID-19 admitted to the ICU, 1,118 (53.3%) were intubated at day 1 and remained under mechanical ventilation at day three. From days 1 to 3, PaO2/FiO2 increased from 115.6 [80.0-171.2] to 180.0 [135.4-227.9] mmHg and the ventilatory ratio from 1.73 [1.33-2.25] to 1.96 [1.61-2.40]. In-hospital mortality was 38.7%. A higher increase between ICU admission and day 3 in the ventilatory ratio (OR 1.04 [CI 1.01-1.07], p = 0.030) and creatinine levels (OR 1.05 [CI 1.01-1.09], p = 0.005) and a lower increase in platelet counts (OR 0.96 [CI 0.93-1.00], p = 0.037) were independently associated with a higher risk of death. No association between mortality and the PaO2/FiO2 variation was observed (OR 0.99 [CI 0.95 to 1.02], p = 0.47). Conclusions: Higher ventilatory ratio and its increase at day 3 is associated with mortality in patients with COVID-19 receiving mechanical ventilation at ICU admission. No association was found in the PaO2/FiO2 variation

Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

Background Acute respiratory distress syndrome (ARDS) can be classified into sub-phenotypes according to different inflammatory/clinical status. Prognostic enrichment was achieved by grouping patients into hypoinflammatory or hyperinflammatory sub-phenotypes, even though the time of analysis may change the classification according to treatment response or disease evolution. We aimed to evaluate when patients can be clustered in more than 1 group, and how they may change the clustering of patients using data of baseline or day 3, and the prognosis of patients according to their evolution by changing or not the cluster.Methods Multicenter, observational prospective, and retrospective study of patients admitted due to ARDS related to COVID-19 infection in Spain. Patients were grouped according to a clustering mixed-type data algorithm (k-prototypes) using continuous and categorical readily available variables at baseline and day 3.Results Of 6205 patients, 3743 (60%) were included in the study. According to silhouette analysis, patients were grouped in two clusters. At baseline, 1402 (37%) patients were included in cluster 1 and 2341(63%) in cluster 2. On day 3, 1557(42%) patients were included in cluster 1 and 2086 (57%) in cluster 2. The patients included in cluster 2 were older and more frequently hypertensive and had a higher prevalence of shock, organ dysfunction, inflammatory biomarkers, and worst respiratory indexes at both time points. The 90-day mortality was higher in cluster 2 at both clustering processes (43.8% [n = 1025] versus 27.3% [n = 383] at baseline, and 49% [n = 1023] versus 20.6% [n = 321] on day 3). Four hundred and fifty-eight (33%) patients clustered in the first group were clustered in the second group on day 3. In contrast, 638 (27%) patients clustered in the second group were clustered in the first group on day 3.Conclusions During the first days, patients can be clustered into two groups and the process of clustering patients may change as they continue to evolve. This means that despite a vast majority of patients remaining in the same cluster, a minority reaching 33% of patients analyzed may be re-categorized into different clusters based on their progress. Such changes can significantly impact their prognosis

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

¿Son aplicables y útiles los indicadores de rendimiento bibliotecario (Norma UNE 50137) para las bibliotecas hospitalarias?

Are applicable and useful librarian performance indicators (UNE 50137 standard) for hospital libraries? Objectives: Test the effectiveness of librarian performance indicators as a tool to assess Health Science and Hospital libraries and try to define those that would be are considered most relevant for this type of libraries. Material and methods: We selected 6 performance indicators (UNE 50137) that we considered would be easy to obtain and we try to reliably achieve the same data in 4 Hospital libraries with similar features. We unifyed measurement criteria to perform calculations, in order to perform a reliable comparisson, and annual calculations to: patrons costs; visits to the library per capita; cost per visit to the library; speed of services of document obtaining; volume of loans; loans per capita. In some cases it was necessary to extract representative samples, obtained randomly so as not to bias the results. All these calculations were performed using the annual accounting information and statistical data obtained as common tasks of libraries. Results: A table was elaborated synthesizing the main results obtained for the 6 selected indicators was elaborated. Conclusions: It is very complicated to apply the same criteria measurement in the different libraries because we do not collect the same data or in the same way, and we do not have accurate and homogeneous measurement systems. The criteria and methodology for data collection has to be unifyed to obtain valid and comparable indicators. These data and these indicators are not really representative of our work. Discussion: can UNE 50137 standard apply for hospital libraries? Do the indicators really measure performance in the field of hospital libraries? To what extent are these data useful

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-IFNα + ribavirin anti-HCV therapy. Plasma samples at baseline and week 24 after SVR were used to perform neutralization assays against five JFH1-based HCV recombinant viruses coding for E1 and E2 from genotypes 1a (H77), 1b (J4), 2a (JFH1), 3a (S52) and 4a (ED43). At baseline, the majority of plasma samples neutralized 1a, 1b, 2a, and 4a, but not 3a, genotypes. Twenty-four weeks following SVR, most neutralizing titers declined substantially. Furthermore, titers against 3a and 2a were not detected in many patients. Plasma samples with high HCV-nAb titers neutralized all genotypes, and the highest titers at the starting point correlated with the highest titers at week 24 after SVR. In conclusion, high titers of broad-spectrum HCV-nAbs were detected in HIV/HCV-coinfected individuals, however, those titers declined soon after SVR